NOVOTECH CRO ATTRACTS INVESTMENT FOR ASIA CLINICAL TRIAL EXPANSION
Sydney, Australia, 6 May, 2013 – Novotech, Australia's largest independent CRO today announced a funding injection from private equity firm Mercury Capital. (www.mercurycapital.com.au)...
TFS acquires US Oncology and Vaccine specialist Beardsworth Consulting Group, Inc.
LUND, Sweden -- On April 26th, 2013, TFS International (TFS) has completed the acquisition of the New Jersey based Oncology and Vaccine specialist Contract Research Organization (CRO), Beardsworth...
Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
-- Raises FY2013 Pro Forma EPS Target to $3.00 to $3.20 -- PRINCETON, N.J. -- Covance Inc. (NYSE: CVD) today reported results for its first quarter ended March 31, 2013. Net revenue was $580...
PAREXEL International Announces Acquisition of HERON Group LTD, a Leading Commercialization Consultancy
Boston, MA, April 30, 2013 – PAREXEL International Corporation (Nasdaq: PRXL), a global clinical research organization, announced that today the Company acquired all of the outstanding equity...
PAREXEL INTERNATIONAL REPORTS THIRD QUARTER FISCAL YEAR 2013 RESULTS
Service revenue of $454.5 million, up 27.7% year-over-year GAAP operating margin of 8.1% improves sequentially from 7.4% in the second quarter CRS gross margin improves sequentially to 27.9% from...
PGXL and Silicon Biosystems Collaborate to Offer Clinical Research Services Focused on Oncology Genomics
LOUISVILLE, Ky.--PGXL Technologies and Silicon Biosystems, Inc. announced a collaborative partnership to make the highly regarded Silicon Biosystems DEPArray technology available through PGXL...
Ergomed and CEL-SCI Sign Co-Development Agreement for Multikine in Head and Neck Cancer
London,UK April 24, 2013 – Ergomed Clinical Research Ltd. ("Ergomed") today announced the signing of a co-development and revenue sharing agreement with CEL-SCI Corporation (NYSE MKT: CVM) for...
AMRI and Ono Broaden SMARTSOURCING™ Collaboration
New Agreement Extends Drug Discovery and Development Collaboration Between the Companies Albany, NY (April 23, 2013) – AMRI (NASDAQ: AMRI) announced today that it has entered into a new...
Catalent Biologics Announces Official Opening of New Single-Use Biomanufacturing Center of Excellence at BIO International Convention
State-of-the-art cGMP facility quadruples biomanufacturing capacity, extensively utilizes single-use technology for greater flexibility and efficiency SOMERSET, NJ — Catalent Pharma Solutions,...
Biocon delivers a strong performance of 18% Revenue Growth in FY13 driven by an evolving Product Portfolio & Research Services...
Commenting on the results, Chairman and Managing Director, Kiran Mazumdar-Shaw stated, "We are pleased to close fiscal 2013 on a very strong note. The key contributors to growth this fiscal have...
ICON Reports First Quarter 2013 Revenue of $317 Million, up 26% year on year and non-GAAP EPS of 36c.
Highlights — First Quarter Fiscal 2013. Quarter 1 net revenue increased 26% year on year to $317 million. Income from operations, excluding restructuring and other items, was $27.4 million...
New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
BOSTON, April 22, 2013 -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today released a new research report called Strategic Partnerships 2013 at...
Quintiles Wins Best CRO Award at World Vaccine Congress 2013
RESEARCH TRIANGLE PARK, N.C.--For the second consecutive year, Quintiles has been named Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Awards. Presented at the...
ICON plc and UCD Smurfit School launch the ICON Business Academy
Dublin, Ireland, 17 April, 2013 – ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, in...
Japanese CRO CAC EXICARE Teams with Medidata to Improve Customers' Clinical Trial Efficiency and Effectiveness Through Cloud Technology
NEW YORK & TOKYO--Japan-based contract research organization (CRO) CAC EXICARE has joined Medidata Solutions' (NASDAQ: MDSO) Partner Program to expand its services offerings to support the...
PRA Program Creates Clinical Research Jobs for New Graduates
Kansas Bioscience Authority Grant Supports Innovative Approach RALEIGH, N.C. – April 17, 2013 – PRA, a leading clinical research organization, today announced it received a $400,000 grant...
Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients' Increased Asia Pacific Focus
PRINCETON, N.J., April 16, 2013 -- Covance Inc. (NYSE: CVD), a leading provider of drug development services, today announced completion of the expansion of its central laboratory facility in...
Drug Discovery Unit (DDU), University of Dundee Licenses GVK BIO Online SAR Database (GOSTAR)
HYDERABAD, India--GVK Biosciences (GVK BIO) today announced that it has licensed its Online SAR Database - GOSTAR to the Drug Discovery Unit (DDU) at the University of Dundee. GOSTAR, a manually...
Absorption Systems Partners with Synerzys to Promote Biopharmaceutics Classification System (BCS) Testing of Drugs
American Testing Lab and Indian Consulting Firm Work to Broaden Acceptance of the BCS EXTON, PA – The preclinical contract research organization Absorption Systems, a global leader in...
Shasun Pharmaceuticals Ltd and Debiopharm Group™ enter into licensing agreement for the manufacturing and commercialization of Huperzine-A
LAUSANNE, Switzerland and CHENNAI, India -- Shasun Pharmaceuticals Ltd, a global pharmaceutical contracting organization offering world class capabilities and facilities to provide services and...
